Despite the immense challenges, with the deepening understanding of sepsis immunology and the emergence of new technologies, therapeutic strategies targeting CD8+ T cells are expected to achieve major breakthroughs in the next decade, paving new avenues for improving the prognosis of sepsis patients. The gene discussed is CD8A; the disease is Sepsis.